June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
IOP lowering with cataract surgery alone, cataract/iStent implantation, and cataract/goniotomy in glaucoma patients
Author Affiliations & Notes
  • Christopher McNiel
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
    Western University of Health Sciences, Lebanon, Oregon, United States
  • Jack P Rees
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
  • Facundo Gregorio Sanchez
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
    Discoveries in Sight Research Laboratories, Portland, Oregon, United States
  • Stuart Keith Gardiner
    Discoveries in Sight Research Laboratories, Portland, Oregon, United States
  • Amber Young
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
  • Jonathan Young
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
  • Robert M Kinast
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
    Discoveries in Sight Research Laboratories, Portland, Oregon, United States
  • Emily P Jones
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
  • Steven L Mansberger
    Glaucoma, Legacy Devers Eye Institute, Portland, Oregon, United States
    Discoveries in Sight Research Laboratories, Portland, Oregon, United States
  • Footnotes
    Commercial Relationships   Christopher McNiel, None; Jack Rees, None; Facundo Sanchez, None; Stuart Gardiner, None; Amber Young, None; Jonathan Young, None; Robert Kinast, None; Emily Jones, None; Steven Mansberger, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3164. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher McNiel, Jack P Rees, Facundo Gregorio Sanchez, Stuart Keith Gardiner, Amber Young, Jonathan Young, Robert M Kinast, Emily P Jones, Steven L Mansberger; IOP lowering with cataract surgery alone, cataract/iStent implantation, and cataract/goniotomy in glaucoma patients. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3164.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We compared the changes in intraocular pressure (IOP) induced by cataract surgery alone, cataract surgery/goniotomy (Kahook Dual Blade, New World Medical, Rancho Cucamonga, CA), and cataract surgery/iStent implantation (Glaukos Corp, Laguna Hills, CA) in glaucoma eyes.

Methods : This comparative, retrospective longitudinal cohort study included 162 eyes with cataract surgery alone (n=142 patients), 25 eyes with cataract/iStent implantation (n=24 patients), and 29 cataract/goniotomy eyes (n=23 patients) with 6 month follow-up. We analyzed differences between groups in the change in IOP and number of medications from preoperative to each postoperative timepoint (day 1, week 2 and months 1, 3, and 6), with linear regression and Poisson regression, respectively.

Results : We found no difference in age, gender, preoperative IOP, or preoperative medications (p>.05 for all) between the groups. Diagnoses were primary-open angle 54/216 eyes (25%), normal-tension 10/216 (4.6%), pseudoexfoliation 6/216 (2.7%), and pigmentary 5/216 (2.3%) glaucoma. The control group contained 50/162 (31%) glaucoma patients.
Table 1 shows results for IOP and medication for both groups. The mean preoperative IOP (±SD) for the cataract only, cataract/iStent, and cataract/goniotomy group was 15.47 ± 3.42, 18.72 ± 7.06, and 17.66 ± 5.95, respectively. The IOP of the iStent group was significantly lower than control at Day 1, 3 months and 6 months (p<0.05 for all). The IOP temporarily increased at 2 weeks but this was not significant (p=0.57). The IOP of the goniotomy group was only significantly lower than control at Day 1 postop (p< 0.001). There was no statistically significant reduction at 2 weeks, 3 months or 6 months (p> 0.05 for all).
The reduction in IOP lowering medications did not reach statistical significance when compared to control in any group (p> 0.05 for all).

Conclusions : Among eyes receiving cataract surgery, when compared to control, both goniotomy and iStent lowered the IOP in the immediate postoperative period. Only iStent maintained a statistically significant reduction in IOP at 3- and 6-month follow-up.

This is a 2020 ARVO Annual Meeting abstract.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×